A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Primary Membranous Nephropathy (ZL-1103-014)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
To evaluate the efficacy and safety of efgartigimod IV in Chinese patients with primary membranous nephropathy (pMN).
Epistemonikos ID: f79b14b90f5312997455bd43f888191c6dcc03f5
First added on: Feb 19, 2024